1. Home
  2. ALTS vs HLVX Comparison

ALTS vs HLVX Comparison

Compare ALTS & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALTS
  • HLVX
  • Stock Information
  • Founded
  • ALTS 1976
  • HLVX 2020
  • Country
  • ALTS United States
  • HLVX United States
  • Employees
  • ALTS N/A
  • HLVX N/A
  • Industry
  • ALTS
  • HLVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALTS
  • HLVX Health Care
  • Exchange
  • ALTS NYSE
  • HLVX Nasdaq
  • Market Cap
  • ALTS 84.1M
  • HLVX 92.9M
  • IPO Year
  • ALTS N/A
  • HLVX 2022
  • Fundamental
  • Price
  • ALTS $5.76
  • HLVX $1.83
  • Analyst Decision
  • ALTS
  • HLVX Hold
  • Analyst Count
  • ALTS 0
  • HLVX 5
  • Target Price
  • ALTS N/A
  • HLVX $2.33
  • AVG Volume (30 Days)
  • ALTS 231.2K
  • HLVX 173.3K
  • Earning Date
  • ALTS 11-12-2024
  • HLVX 03-19-2025
  • Dividend Yield
  • ALTS N/A
  • HLVX N/A
  • EPS Growth
  • ALTS N/A
  • HLVX N/A
  • EPS
  • ALTS N/A
  • HLVX N/A
  • Revenue
  • ALTS $7,110,000.00
  • HLVX N/A
  • Revenue This Year
  • ALTS N/A
  • HLVX N/A
  • Revenue Next Year
  • ALTS N/A
  • HLVX N/A
  • P/E Ratio
  • ALTS N/A
  • HLVX N/A
  • Revenue Growth
  • ALTS N/A
  • HLVX N/A
  • 52 Week Low
  • ALTS $0.60
  • HLVX $1.55
  • 52 Week High
  • ALTS $7.09
  • HLVX $20.22
  • Technical
  • Relative Strength Index (RSI)
  • ALTS 52.01
  • HLVX 46.23
  • Support Level
  • ALTS $4.60
  • HLVX $1.86
  • Resistance Level
  • ALTS $6.64
  • HLVX $1.97
  • Average True Range (ATR)
  • ALTS 0.65
  • HLVX 0.07
  • MACD
  • ALTS -0.05
  • HLVX -0.00
  • Stochastic Oscillator
  • ALTS 53.21
  • HLVX 34.09

About ALTS ALT5 SIGMA CORPORATION

ALT5 Sigma Corp is a fintech company. It is providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment and safe-keeping of digital assets. The company product include ALT 5 Prime is an electronic over-the-counter trading platform and ALT 5 Pay crypto payment processor.

About HLVX HilleVax Inc.

HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.

Share on Social Networks: